BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+22.4%
5Y CAGR+15.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+22.4%/yr
vs +8.0%/yr prior
5Y CAGR
+15.4%/yr
Recent acceleration
Acceleration
+14.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.51B | +49.5% |
| 2024 | $1.01B | +13.1% |
| 2023 | $892.40M | +8.4% |
| 2022 | $823.20M | +8.4% |
| 2021 | $759.40M | +2.9% |
| 2020 | $737.70M | +8.3% |
| 2019 | $680.90M | +12.7% |
| 2018 | $604.40M | +9.0% |
| 2017 | $554.34M | +16.3% |
| 2016 | $476.59M | - |